LY2795050

1346133-08-1

C23H22ClN3O2

DMSO : 83.3 mg/mL (204.22 mM; Need ultrasonic)

GPCR/G Protein; Neuronal Signaling

LY2795050 is a novel selective kappa-opioid Receptor (KOR) antagonist (IC50=0.72 nM) and has the potential as a PET tracer to image KOR in vivo. IC50 Value: 0.72 nM (kappa-opioid Receptor); 25.8 nM (kappa-opioid) [1] Target: kappa-opioid Receptor in vitro: LY2795050 displays full antagonist activity and high binding affinity and selectivity for KOR with a ki value of 0.72 nM [1]. in vivo: In the brain, (11)C-LY2795050 displayed fast uptake kinetics (regional activity peak times of <20 min) and an uptake pattern consistent with the distribution of KOR in primates [1]. The LY2795050 ED50 at MOR was 119 ug/kg based on a 1-site model for 11C-carfentanil. The 1-site binding model was also deemed sufficient to describe the specific binding of 11C-LY2795050 at KOR. The ED50 at KOR estimated from the 1-site model was 15.6 ug/kg. Thus, the ED50 ratio for MOR:KOR was 7.6 [2].